Latest scientific publications

  • Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study.

  • Auteurs Alsoud D, Sabino J, Franchimont D, Cremer A, Busschaert J, D'Heygere F, Bossuyt P, Vijverman A, Vermeire S, Ferrante M
  • Auteurs (entité) Franchimont Denis
  • Revue Inflamm Bowel Dis
  • Date de publication 2024-01
Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study.
  • Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study.

  • Auteurs Alsoud D, Sabino J, Franchimont D, Cremer A, Busschaert J, D'Heygere F, Bossuyt P, Vijverman A, Vermeire S, Ferrante M
  • Auteurs (entité) Cremer Anneline
  • Revue Inflamm Bowel Dis
  • Date de publication 2024-01
Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study.
  • The Utilisation of Digital Applications for Measuring Patient Outcomes Following Bariatric Surgery: a Systematic Review and Meta-analysis of Comparative Studies.

  • Auteurs Farinella E, Koliakos N, Papakonstantinou D, Breuer N, Pau L, Poras M, Maréchal MT, Briganti G
  • Auteurs (entité) Farinella Eleonora
  • Revue Obes Surg
  • Date de publication 2024-01
The Utilisation of Digital Applications for Measuring Patient Outcomes Following Bariatric Surgery: a Systematic Review and Meta-analysis of Comparative Studies.
Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Erasme hospital

Erasmus Hospital

View all of Erasmus's scientific publications

Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital